AJJ Medtech's Q1 Attributable Loss Widens 141%; Shares Slump 17%

MT Newswires05-15

AJJ Medtech's (SGX:584) attributable loss to equity holders widened to SG$563,000 in the first quarter from SG$234,000 a year earlier, according to a Thursday filing with the Singapore Exchange.

Shares of the healthcare technology company sank nearly 17% in Friday trading.

Loss per share came in at SG$0.00033 compared with SG$0.00016 in the year-ago period.

Revenue declined 51% year over year to SG$465,000 from SG$945,000.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment